← Open Payments lookup

JESSICA SINCLAIR: Open Payments

NPI 1891148011 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$855 in 49 payments from 12 companies in 2025. Trend: 2023 $370 · 2024 $520 · 2025 $855

Food & beverage: $855
CompanyPaymentsAmount
Lilly USA, LLC13$194
ABBVIE INC.14$177
Phathom Pharmaceuticals, Inc.4$152
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$54
Amgen Inc.3$52
Novo Nordisk Inc3$51
Boehringer Ingelheim Pharmaceuticals, Inc.2$49
Abbott Laboratories2$39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$33
AstraZeneca Pharmaceuticals LP1$23

Products named: MOUNJARO, VOQUEZNA, UBRELVY, QULIPTA, XIFAXAN, VRAYLAR, OTEZLA, CAPLYTA.

Industry payments across MS — which companies pay providers there.